Synthesis and in vitro evaluation of some new pyrimidines and related condensed ring systems as potential anticancer agents

Journal of Heterocyclic Chemistry

Volumn 33, Issue 2, 1996, Pages 229-233

  Badawey, El Sayed A M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLORO 5 (2 CHLOROETHYL) 2 METHYLTHIO 6 METHYLPYRIMIDINE; ANTINEOPLASTIC AGENT; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; TUMOR CELL;

EID: 0029891107     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570330202     Document Type: Article

References (13)

1. E. Badawey and T. Kappe, Eur. J. Med. Chem., 30, 327 (1995).
2. E. Badawey and T. Kappe, J. Heterocyclic Chem., 32, 1003 (1995).
3. B. K. Bhattacharya, B. A. Otter, R. L. Berens and R. S. Klein, Nucleosides Nucleotides, 9, 1021 (1990); Chem. Abstr., 114, 207671n (1991).
4. B. K. Bhattacharya, B. A. Otter, R. L. Berens and R. S. Klein, Nucleosides Nucleotides, 9, 1021 (1990); Chem. Abstr., 114, 207671n (1991).
5. E. C. Taylor, D. Kuhnt, C. Shih, S. M. Rinzel, G. B. Grindey, J. Barredo, M. Jannatipour and R. G. Moran, J. Med. Chem., 35, 4450 (1992).
6. T. Hitaka, H. Akimoto and H. Nomura, J. Med. Chem., 34, 555 (1991).
7. T. Takeuchi, H. Nishioka, T. Sawa, H. Iinuma, K. Umezawa, H. Osanawa and M. Hamada, Japan Kokai Tokkyo Koha JP 04,217,681 [92,217,681] (Cl. C07D487/04) (1992); Chem. Abstr., 117, 190279c (1992).
8. M. Kawanishi, Tanabe Seiyaku Kenkyu Nempo, 3, 4 (1958); Chem. Abstr., 52, 20184a (1958).
9. M. Kawanishi, Tanabe Seiyaku Kenkyu Nempo, 3, 4 (1958); Chem. Abstr., 52, 20184a (1958).
10. Y. Kuwayama, Yakugaku Zasshi, 82, 1028 (1962); Chem. Abstr., 58, 5687 (1963).
11. Y. Kuwayama, Yakugaku Zasshi, 82, 1028 (1962); Chem. Abstr., 58, 5687 (1963).
12. S. Furukawa, M. Takada and R. N. Castle, J. Heterocyclic Chem., 18, 581 (1981).
13. Conducted by the National Cancer Institute, Bethesda, Maryland, USA.